These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29434217)

  • 1. IL-23 and IL-27 Levels in Serum are Associated with the Process and the Recovery of Guillain-Barré Syndrome.
    Peng J; Zhang H; Liu P; Chen M; Xue B; Wang R; Shou J; Qian J; Zhao Z; Xing Y; Liu H
    Sci Rep; 2018 Feb; 8(1):2824. PubMed ID: 29434217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome.
    Zhao Z; Zhang R; Gao X; Li H; Liu H
    Medicine (Baltimore); 2020 Dec; 99(52):e23832. PubMed ID: 33350771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies to ganglioside GM1 and Campylobacter jejuni in patients with Guillain-Barré syndrome].
    Basta I; Suturkova L; Vujić A; Aleksić S; Poceva A; Paskoska A; Milenikova K; Trikić R; Apostolski S
    Srp Arh Celok Lek; 2005; 133(3-4):123-8. PubMed ID: 16206698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome.
    Li S; Yu M; Li H; Zhang H; Jiang Y
    Mediators Inflamm; 2012; 2012():260473. PubMed ID: 23091305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.
    Koga M; Takahashi M; Yokoyama K; Kanda T
    J Neurol; 2015 Aug; 262(8):1954-60. PubMed ID: 26050638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome.
    Nyati KK; Prasad KN; Rizwan A; Verma A; Paliwal VK
    Arch Neurol; 2011 Apr; 68(4):445-52. PubMed ID: 21482924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.
    Islam Z; Gilbert M; Mohammad QD; Klaij K; Li J; van Rijs W; Tio-Gillen AP; Talukder KA; Willison HJ; van Belkum A; Endtz HP; Jacobs BC
    PLoS One; 2012; 7(8):e43976. PubMed ID: 22952833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments.
    Li S; Jin T; Zhang HL; Yu H; Meng F; Concha Quezada H; Zhu J
    Mediators Inflamm; 2014; 2014():740947. PubMed ID: 24899787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options.
    Ebrahim Soltani Z; Rahmani F; Rezaei N
    Eur Cytokine Netw; 2019 Mar; 30(1):1-14. PubMed ID: 31074417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of serum interleukin-27 and interleukin-35 concentrations in patients with Guillain-Barré syndrome.
    Zhang LJ; Guo HY; Zhang DQ; Wang R; Li T; Li LM; Suo DM; Yang L
    Clin Chim Acta; 2017 May; 468():5-9. PubMed ID: 28167198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
    St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
    J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
    Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
    Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of IVIg therapy on serum levels of neuropeptide Y and cytokines in Guillain-Barré syndrome.
    Li C; Luo T; Cheng Y; Liu S; Qiao L; Wu X; Liu K
    Neurol Sci; 2020 Feb; 41(2):295-303. PubMed ID: 31494821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ganglioside antibodies in patients with Guillain Barré syndrome and other neurological disorders.
    Vaishnavi C; Behura C; Prabhakar S; Sharma A; Kharbanda P
    Indian J Med Microbiol; 2013; 31(2):177-9. PubMed ID: 23867676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antibodies against Campylobacter jejuni serogroup PEN O:19 purified flagellar protein in a patient with Guillain-Barré syndrome.
    Lange D; Aleksic S; Kassubek J; Vrvic MM; Kist M; Steinbrückner B; Mitova M
    Zentralbl Bakteriol; 1999 Oct; 289(4):429-44. PubMed ID: 10603661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
    J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group.
    Press R; Deretzi G; Zou LP; Zhu J; Fredman P; Lycke J; Link H
    J Neuroimmunol; 2001 Jan; 112(1-2):129-38. PubMed ID: 11108941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
    Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
    Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.